Biblio
Found 2636 results
Author [ Keyword![(Asc)](https://www.niagads.org/sites/all/modules/contrib/biblio/misc/arrow-asc.png)
Filters: First Letter Of Last Name is R [Clear All Filters]
“Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.”, Nat Genet, vol. 43, no. 5, pp. 429-35, 2011.
, “Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.”, Nat Genet, vol. 43, no. 5, pp. 429-35, 2011.
, “Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.”, Nat Genet, vol. 43, no. 5, pp. 436-41, 2011.
, “Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.”, Nat Genet, vol. 43, no. 5, pp. 436-41, 2011.
, “Genetic variants conferring susceptibility to Alzheimer's disease in the general population; do they also predispose to dementia in Down's syndrome.”, BMC Res Notes, vol. 7, p. 42, 2014.
, “Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.”, Nat Genet, vol. 43, no. 5, pp. 436-41, 2011.
, “Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.”, Nat Genet, vol. 43, no. 5, pp. 436-41, 2011.
, “Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias.”, PLoS Genet, vol. 10, no. 9, p. e1004606, 2014.
, “Genetic control of human brain transcript expression in Alzheimer disease.”, Am J Hum Genet, vol. 84, no. 4, pp. 445-58, 2009.
, “Genetic control of human brain transcript expression in Alzheimer disease.”, Am J Hum Genet, vol. 84, no. 4, pp. 445-58, 2009.
, “Genetic control of human brain transcript expression in Alzheimer disease.”, Am J Hum Genet, vol. 84, no. 4, pp. 445-58, 2009.
, “Alzheimer's disease: analyzing the missing heritability.”, PLoS One, vol. 8, no. 11, p. e79771, 2013.
, “Heritability of the shape of subcortical brain structures in the general population.”, Nat Commun, vol. 7, p. 13738, 2016.
, , “Fine mapping of 10q and 18q for familial Alzheimer's disease in Caribbean Hispanics.”, Mol Psychiatry, vol. 9, no. 11, pp. 1042-51, 2004.
, “Fine mapping of 10q and 18q for familial Alzheimer's disease in Caribbean Hispanics.”, Mol Psychiatry, vol. 9, no. 11, pp. 1042-51, 2004.
, “Analysis of lipid pathway genes indicates association of sequence variation near SREBF1/TOM1L2/ATPAF2 with dementia risk.”, Hum Mol Genet, vol. 19, no. 10, pp. 2068-78, 2010.
, “A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease.”, Nat Neurosci, vol. 20, no. 8, pp. 1052-1061, 2017.
, “A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease.”, Nat Neurosci, vol. 20, no. 8, pp. 1052-1061, 2017.
, “The Mount Sinai cohort of large-scale genomic, transcriptomic and proteomic data in Alzheimer's disease.”, Sci Data, vol. 5, p. 180185, 2018.
, “The Mount Sinai cohort of large-scale genomic, transcriptomic and proteomic data in Alzheimer's disease.”, Sci Data, vol. 5, p. 180185, 2018.
, “Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease.”, Nature, vol. 505, no. 7484, pp. 550-554, 2014.
, “Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease.”, Nature, vol. 505, no. 7484, pp. 550-554, 2014.
, “Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease.”, Nature, vol. 505, no. 7484, pp. 550-554, 2014.
, “The neuronal sortilin-related receptor gene SORL1 and late-onset Alzheimer's disease.”, Curr Neurol Neurosci Rep, vol. 8, no. 5, pp. 384-91, 2008.
,